A Phase I/II Trial of ABI-008 (nab-docetaxel) in Patients with Metastatic Breast Cancer
Phase of Trial: Phase I/II
Latest Information Update: 11 Jun 2009
At a glance
- Drugs Docetaxel (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Abraxis BioScience
- 11 Jun 2009 Last checked against ClinicalTrials.gov record.
- 06 Nov 2008 Status changed from active, no longer recruiting to discontinued, based on information from ClinicalTrials.gov.
- 10 Mar 2008 The expected completion date for this trial is now 1 Dec 2008.